New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 24, 2014
09:47 EDTHUMHumana says evaluating changes detailed in CMS Medicare Advantage notice
Humana stated in a regulatory filing that on Friday, February 21, after the stock market close, the Centers for Medicare and Medicaid Services, or CMS, issued its Advance Notice detailing preliminary 2015 Medicare Advantage benchmark payment rates. CMS has invited public comment on these preliminary rates before releasing final rates on April 7. In the company’s earnings release call for Q4 held on February 5, the company discussed that it anticipated the Advance Notice would result in a decline in Medicare Advantage funding of 6%-7% for 2015, including the impact of the industry fee. "Based upon the 2015 Advance Notice, these same factors as well as the potential impact of CMS’s proposed changes to the calculation of Fee-for-Service, or FFS, costs are now expected to result in a funding decline for 2015 of 3.5%-4.0%," Humana said. The Advance Notice also proposes changes associated with enrollee risk assessments that would potentially result in additional significant funding declines. Humana will be providing comments to CMS in support of this critical program. Humana said, "The company is continuing to evaluate the changes detailed in the Advance Notice and the related impact company-wide and by geography. Further, Humana is closely analyzing all operational avenues to address the 2015 preliminary rates and the related impacts upon the company’s Medicare membership and its earnings for 2015. Humana is committed to providing quality care and service to its members through the Medicare Advantage program. The company will be drawing upon its program expertise to comment on the impact of these preliminary rate changes upon beneficiaries as it provides comments to CMS."
News For HUM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 10, 2016
07:35 EDTHUMHumana recorded premium deficiency reserve totaling $176M pretax in Q4
During 4Q 2015, the company recorded a premium deficiency reserve totaling $176 million pretax, or 74c per share, related to certain of its 2016 individual commercial policies.
07:34 EDTHUMHumana reports Q4 adjusted EPS $1.45, consensus $1.45
Subscribe for More Information
07:34 EDTHUMHumana sees 2016 projected net membership growth in standalone PDP 300K-330K
Subscribe for More Information
07:33 EDTHUMHumana sees Q1 adjusted EPS 'at least' $1.80, consensus $2.50
Subscribe for More Information
07:32 EDTHUMHumana sees FY16 adjusted EPS 'at least' $8.85, consensus $8.73
Subscribe for More Information
07:31 EDTHUMHumana reports Q4 EPS $1.45, consensus $1.45
Subscribe for More Information
February 9, 2016
14:36 EDTHUMNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Time Warner (TWX), consensus $1.01... Humana (HUM), consensus $1.45... Owens Corning (OC), consensus 45c... Carlyle Group (CG), consensus 31c... Medidata (MDSO), consensus 24c.
February 7, 2016
14:45 EDTHUMLeerink healthcare services analyst holds analyst/industry conference call
Subscribe for More Information
February 1, 2016
06:03 EDTHUMAetna on track to close Humana transaction in 2H16
The company commented, "We continue to work diligently with the Department of Justice and state regulators toward final approval of our proposed acquisition of Humana, and we continue to advance our integration readiness plans. We have obtained seven of the necessary state approvals, and we believe we remain on track to close the transaction in the second half of 2016."
January 29, 2016
14:24 EDTHUMEarnings Watch: Aetna down 9% since last report
Aetna (AET) is scheduled to report fourth quarter earnings before the market open on Monday, February 1, with a conference call scheduled for 8:30 am ET. Aetna, a diversified health care benefits company in the United States, operates in three segments: Health Care, Group Insurance, and Large Case Pensions. EXPECTATIONS: Analysts are looking for earnings per share of $1.21 on revenue of $14.93B, according to First Call. The consensus range for EPS is $1.16-$1.32 on revenue of $14.44B-$15.36B. LAST QUARTER: Aetna reported third quarter EPS of $1.90 on revenue of $14.97B against analyst estimates of $1.77 and $14.95B, respectively. The company raised its fiscal 2015 EPS view to $7.45-$7.55 from "at least $7.40." Operating earnings were $668.6M for Q315 compared with $638.6M for Q314. The increase in operating earnings was primarily due to higher underwriting margins in Aetna's Health Care segment, partially offset by an increase in general and administrative expenses and lower underwriting margins in Aetna's Group Insurance segment. On January 11, Aetna said it see FY15 EPS at the high end of the $7.45-$7.55 range. Consensus for FY15 EPS is $7.54. STREET RESEARCH: On January 15, Wells Fargo said it expects health insurers' stock to do well this year, as the firm expects M&A deals made the last years to increase profits this year, and it thinks investors should be attracted to what it sees as the defensive names in the sector. Wells does not believe that any changes to or replacements of the ACA will be worse for the sector than the status quo. It identified Aetna and HCA Holdings (HCA) as its favorite names in the sector. On January 25, Leerink analyst Ana Gupte said she believed the recent selloff has provided a "strong" buying opportunity in the Managed Care space. Valuations are attractive on multiple metrics, Gupte told investors in a research note. Her top picks are UnitedHealth (UNH), Aetna, Humana (HUM) and Molina Healthcare (MOH). The analyst also favors Anthem (ANTM) and Cigna (CI). PRICE ACTION: Shares of Aetna are down approximately 9% since its last earnings report. The stock is up 2.6% to $101.42 in Friday afternoon trading ahead of Monday morning's report.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use